Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Joanna Moschandreas

BSc (Sheffield), MSc (Oxford), MSc (Edinburgh), PhD (Crete)


Senior Statistician

I joined the Centre for Prevention of Stroke and Dementia (CPSD) as a senior statistician in April 2019, where I am currently involved in the meta-analysis of randomised controlled trials of aspirin treatment for the primary and secondary prevention of major vascular events. I am also a statistical adviser for the Research Design Service South Central, where my role involves advising researchers on the design and statistical content of proposals being prepared for submission to national funding bodies. My previous appointments were at the Centre for Statistics in Medicine (CSM) Oxford Clinical Trials Research Unit (OCTRU), 2015-2019, and the Department of Social Medicine at the University of Crete Medical School (Assistant Professor, 2008-2015). At CSM/OCTRU my role included providing input to the design, running, analysis and reporting of both early and late phase cancer clinical trials and feasibility studies. I am experienced in teaching medical statistics to students, postgraduates and health professionals. I am a facilitator on the annual RCT course run by CSM. I have supervised both undergraduate and postgraduate projects.

I am a member of the NIHR Statistics group – ophthalmology research section and the Ophthalmic Statistics Group. I am also an external reviewer for proposals and study reports submitted to the NIHR. I have served as a statistical adviser on the editorial boards of the Annals of Gastroenterology and BMC Ophthalmology. In 2011, I spent two months at the University of Minnesota as a Fulbright Research Scholar investigating the potential use of rank preserving structural failure time models in assessing the effect of smoking cessation on cardiovascular outcomes in an observational study comprising 16 cohorts followed up over a 40-year period.